Nang Kuang Pharmaceutical Co., Ltd. (TPE:1752)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
33.60
-0.25 (-0.74%)
Apr 29, 2026, 1:30 PM CST
-6.01%
Market Cap 3.39B
Revenue (ttm) 2.16B
Net Income (ttm) 244.41M
Shares Out 100.99M
EPS (ttm) 2.41
PE Ratio 13.94
Forward PE n/a
Dividend 1.60 (4.73%)
Ex-Dividend Date Jul 3, 2025
Volume 124,074
Average Volume 72,669
Open 33.85
Previous Close 33.85
Day's Range 33.50 - 33.85
52-Week Range 33.50 - 40.70
Beta 0.24
RSI 16.90
Earnings Date May 5, 2026

About Nang Kuang Pharmaceutical

Nang Kuang Pharmaceutical Co., Ltd. manufactures, processes, trades in, imports, and exports pharmaceuticals and medical devices in Taiwan, China, Japan, the United States, and internationally. The company offers ready to use injections, such as prefilled syringe injections and premixed IV infusions; anti-aging and preventive medicines; chemotherapy and oncology products; and non-PVC IV infusion. It also provides various products in the areas of cardiovascular, gastrointestinal, nervous, musculo-skeletal, and respiratory system, as well as in a... [Read more]

Sector Healthcare
Founded 1963
Employees 552
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 1752
Full Company Profile

Financial Performance

In 2025, Nang Kuang Pharmaceutical's revenue was 2.16 billion, a decrease of -1.71% compared to the previous year's 2.20 billion. Earnings were 244.41 million, an increase of 0.41%.

Financial Statements

News

There is no news available yet.